{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:42:34Z","timestamp":1790872954686,"version":"4.1.0"},"reference-count":21,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T00:00:00Z","timestamp":1405987200000},"content-version":"vor","delay-in-days":4707,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2001,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We measured serum levels of SP\u2010D in collagen diseases (110 cases) such as systemic scleroderma (SSc), scleroderma spectrum disorders (SSD), systemic lupus erythematodes (SLE), Sj\u00f6gren syndrome (Sjs), dermatomyositis (DM), rheumatoid arthritis (RA), and dermatitis (DE) (109 cases) as a control. Additionally, we performad a correlation analysis to determine how these levels were related to pulmonary fibrosis and function test (vital capacity, %DLco). The serum levels of SP\u2010D increased in SSc patients with Barnett type III more than in SSc patients with Barnett type I or II, while they increased slightly in SSD (incomplete type of SSc) patients. The differences in these figures were statistically significant between the SSc (SSc &amp; SSD) and non\u2010SSc (SLE, DM, Sjs &amp; RA) groups (p&lt;0.005). The serum levels of SP\u2010D in SSc patients with anti\u2010topoisomerase I antibodies were statistically higher than those in SSc patients with other types of anti\u2010nuclear antibodies. There was a statistically significant correlation between the severity of pulmonary fibrosis and the serum levels of SP\u2010D, and a statistically negative correlation between SP\u2010D levels and vital capacity or %DLco, but there was no proportional correlation with the forced expiatory volume (FEV<jats:sub>1.0%<\/jats:sub>). There was no statistical relationship between pre\u2010 and post\u2010therapy with photopheresis; however, there was a statistical correlation between the serum levels of SP\u2010D and KL\u20106. In the group of collagen diseases, plasma levels of SP\u2010D were higher than serum levels of SP\u2010D. Patients with SSc possess higher levels of SP\u2010D than do those with other collagen diseases and dermatitis, which may correspond to the severity of pulmonary fibrosis.<\/jats:p>","DOI":"10.1111\/j.1346-8138.2001.tb00013.x","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T10:55:31Z","timestamp":1406026531000},"page":"467-474","source":"Crossref","is-referenced-by-count":16,"title":["Surfactant Protein D (SP\u2010D) and Systemic Scleroderma (SSc)"],"prefix":"10.1111","volume":"28","author":[{"given":"Manabu","family":"Maeda","sequence":"first","affiliation":[{"name":"Department of Dermatology Gifu Prefectural Hospital  Gifu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Ichiki","sequence":"additional","affiliation":[{"name":"Department of Dermatology Gifu University, School of Medicine  Gifu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Aoyama","sequence":"additional","affiliation":[{"name":"Department of Dermatology Gifu University, School of Medicine  Gifu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Kitajima","sequence":"additional","affiliation":[{"name":"Department of Dermatology Gifu University, School of Medicine  Gifu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"key":"e_1_2_5_2_1","first-page":"71","volume-title":"Scleroderma (Progressive Systemic Sclerosis)","author":"Barnett AJ","year":"1974"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1992.tb03566.x"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1159\/000247216"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0923-1811(95)93712-A"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.1998.275.1.L1"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.1.9903014"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.152.6.8520747"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4439(98)00074-X"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000018382"},{"key":"e_1_2_5_11_1","first-page":"930","article-title":"Serum levels of KL\u20106 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis","volume":"27","author":"Yamane K","year":"2000","journal-title":"J Rheumatol"},{"key":"e_1_2_5_12_1","first-page":"289","article-title":"Early detection of scleroderma spectrum disorders by in vivo capillary microscopy\u2014A prospective study of patients with Raynaud's phenomenon","volume":"9","author":"Maricq HR","year":"1982","journal-title":"J Rheumatol"},{"key":"e_1_2_5_13_1","first-page":"17","volume-title":"Preliminary Diagnostic Criteria in Japan","author":"Mori S","year":"1992"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(97)00124-1"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1991.tb33446.x"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000246481"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70246-X"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4439(98)00073-8"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.12.1.7811466"},{"key":"e_1_2_5_20_1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0171-2985(98)80025-9","article-title":"Structural aspects of collectins and receptors for collectins","volume":"199","author":"Hansen S","year":"1998","journal-title":"Immunobiology"},{"key":"e_1_2_5_21_1","first-page":"554","article-title":"The clinical study on KL\u20106 and SP\u2010D in sera of patients with various pulmonary diseases","volume":"48","author":"Sugimoto H","year":"2000","journal-title":"Rinsho Byori"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200106)44:6<1363::AID-ART229>3.0.CO;2-5"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.2001.tb00013.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1346-8138.2001.tb00013.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T15:44:35Z","timestamp":1700322275000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.2001.tb00013.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1111\/j.1346-8138.2001.tb00013.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.2001.tb00013.x","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}